RoslinCT has been confirmed as a National Training Centre, part of the Department for Business, Energy & Industrial Strategy (BEIS) sponsored Advanced Therapies Skills Training Network (ATSTN) initiative. The organisation is the second National Training Centre confirmed as part of the ATSTN initiative, which was set up to develop vaccine and advanced therapy manufacturing training capabilities online and across the UK.
RoslinCT will work closely with Scottish Universities Life Sciences Alliance, Edinburgh Napier University, Industrial Biotechnology Innovation Centre and Ayrshire College in providing training capabilities complementary to the ones being developed at the National Horizons Centre which focusses on manufacturing techniques.
Aimed at the current advanced therapies and vaccine manufacturing industry workforce, academics and those enrolled in further and higher education, the week-long courses will provide basic, practical training in sterile manufacturing within a cleanroom environment, plus an introduction to Good Manufacturing Practice (GMP) training within an industrial setting.
Janet Downie, CEO of RoslinCT said: “Developing the next generation of highly skilled individuals in the life science sector is key to the UK economy. RoslinCT and the Scottish consortium are delighted to be part of the Advanced Therapies Skills Training Network who are creating the world’s leading training programme in ATMP and vaccine manufacturing”.
Matthew Durdy, CEO of Cell and Gene Therapy Catapult commented: “The UK’s ATMP capabilities are world-leading and growing rapidly. Working with the industry and high profile institutes such as RoslinCT and the Scottish Consortium we can deliver more skilled people to fuel this growth. It is a win-win situation: helping companies, creating career opportunities and accelerating life-changing medicines.”